Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-25T09:15:59.455Z Has data issue: false hasContentIssue false
  • English
  • Français

A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?

Published online by Cambridge University Press:  01 December 2015

Juliana Francisco Cecato ,
José Eduardo Martinelli ,
Rafael Izbicki ,
Mônica Sanches Yassuda  and
Ivan Aprahamian
Juliana Francisco Cecato
Affiliation:
Department of Internal Medicine, Faculty of Medicine of Jundiaí, State of São Paulo, Brazil
José Eduardo Martinelli
Affiliation:
Department of Internal Medicine, Faculty of Medicine of Jundiaí, State of São Paulo, Brazil
Rafael Izbicki
Affiliation:
Department of Statistics, Federal University of São Carlos (UFSCar), State of São Paulo, Brazil
Mônica Sanches Yassuda
Affiliation:
Department of Neurology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil School of Arts, Sciences and Humanities, University of São Paulo, São Paulo, Brazil
Ivan Aprahamian*
Affiliation:
Department of Internal Medicine, Faculty of Medicine of Jundiaí, State of São Paulo, Brazil Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, Brazil
*
Correspondence should be addressed to: Ivan Aprahamian, MD, MS, PhD, FACP, Department of Internal Medicine, Faculty of Medicine of Jundiaí. Rua Francisco Telles, 250, Vila Arens, Jundiaí, São Paulo, ZIP: 13202-550, Brazil. Phone: 55-11 4587-1095. Email: ivan.aprahamian@gmail.com.
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

It is necessary to continue to explore the psychometric characteristics of key cognitive screening tests such as the Montreal Cognitive Assessment (MoCA) to diagnose cognitive decline as early as possible and to attend to the growing need of clinical trials involving mild cognitive impairment (MCI) participants. The main aim of this study was to assess which MoCA subtests could best discriminate between healthy controls (HC), participants with MCI, and Alzheimer's disease (AD).

Methods:

Cross-sectional analysis of 136 elderly with more than four years of education. All participants were submitted to detailed clinical, laboratory, and neuroimaging evaluation. The MoCA, Mini-Mental State Examination (MMSE), the Cambridge Cognitive Examination (CAMCOG), Geriatric Depression Scale (GDS), and Functional Activities Questionnaire (FAQ) were applied to all participants. The MoCA test was not used in the diagnostic procedure.

Results:

Median MoCA total scores were 27, 23 and 18 for HC, MCI, and AD, respectively (p < 0.001). Word repetition, inverse digits, serial 7, phrases, verbal fluency, abstraction, and word recall discriminated between MCI and HC participants (p < 0.001). The clock drawing, the rhino naming, delayed recall of five words and orientation discriminated between patients with MCI and AD (p < 0.001). A reduced version of the MoCA with only these items did not improve accuracy between MCI and HC (p = 0.076) or MCI and AD (p = 0.119).

Conclusions:

Not all MoCA subtests might be fundamental to clinical diagnosis of MCI. The reduced versions of MoCA did not add diagnostic accuracy.

Keywords

mild cognitive impairment diagnosisAlzheimer’s diseasecognitive assessmentcognitive testing
Type
Research Article
Information
International Psychogeriatrics , Volume 28 , Issue 5 , May 2016 , pp. 825 - 832
Copyright
Copyright © International Psychogeriatric Association 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albert, M. S. et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 7, 270–279.CrossRefGoogle ScholarPubMed
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.Google Scholar
Aprahamian, I., Martinelli, J. E., Cecato, J. F., Izbicki, R. and Yassuda, M. S. (2011). Can the CAMCOG be a good cognitive test for patients with Alzheimer's disease with low levels of education? International Psychogeriatrics, 23, 96–101.CrossRefGoogle ScholarPubMed
Brucki, S. M. D., Nitrini, R., Caramelli, P., Bertolucci, P. H. F. and Okamoto, I. (2003). Sugestões para o uso do Mini-Exame do Estado Mental no Brasil. Arquivos de Neuropsiquiatria, 61, 777–781.CrossRefGoogle Scholar
Coen, R. F., Cahill, R. and Lawlor, B. A. (2011). Things to watch out for when using the Montreal cognitive assessment (MoCA). International Journal of Geriatric Psychiatry, 26, 107–108.CrossRefGoogle ScholarPubMed
Costa, A. S. et al. (2012). Alternate-form reliability of the Montreal cognitive assessment screening test in a clinical setting. Dementia and Geriatric Cognitive Disorders, 33, 379–384.CrossRefGoogle ScholarPubMed
Damian, A. M. et al. (2011). The Montreal cognitive assessment and the Mini-Mental State Examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dementia and Geriatric Cognitive Disorders, 31, 126–131.CrossRefGoogle ScholarPubMed
Dixon, R. A., Garrett, D. D., Lentz, T. L., MacDonald, S. W., Strauss, E. and Hultsch, D. F. (2007). Neurocognitive markers of cognitive impairment: exploring the roles of speed and inconsistency. Neuropsychology, 21, 381–399.CrossRefGoogle ScholarPubMed
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.CrossRefGoogle Scholar
Gamaldo, A. A., An, Y., Allaire, J. C., Kitner-Triolo, M. H. and Zonderman, A. B. (2012). Variability in performance: identifying early signs of future cognitive impairment. Neuropsychology, 26, 534–540.CrossRefGoogle ScholarPubMed
Ismail, Z., Rajji, T. K. and Shulman, K. I. (2010). Brief cognitive screening instruments: in update. International Journal of Geriatric Psychiatry, 25, 111–120.CrossRefGoogle ScholarPubMed
Kaya, Y., Aki, O. E., Can, U. A., Derle, E., Kibaro, S. and Barak, A. (2014). Validation of Montreal cognitive assessment and discriminant power of Montreal cognitive assessment subtests in patients with mild cognitive impairment and Alzheimer dementia in Turkish population. Journal of Geriatric Psychiatry and Neurology, 27, 103–107.CrossRefGoogle ScholarPubMed
Lam, B. et al. (2013). Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing. Journal of the American Geriatrics Society, 61, 2181–2185.CrossRefGoogle ScholarPubMed
Luis, C. A., Keegan, A. P. and Mullan, M. (2009). Cross validation of the Montreal cognitive assessment in community dwelling older adults residing in the Southeastern US. International Journal of Geriatric Psychiatry, 24, 197–201.CrossRefGoogle ScholarPubMed
McKhann, G. M. et al. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 7, 263–269.CrossRefGoogle ScholarPubMed
Memória, C. M., Yassuda, M. S., Nakano, E. Y. and Forlenza, O. V. (2013). Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment. International Journal of Geriatric Psychiatry, 28, 34–40.CrossRefGoogle ScholarPubMed
Moafmashhadi, P. and Koski, L. (2013). Limitations for interpreting failure on individual subtests of the Montreal cognitive assessment. Journal of Geriatric Psychiatry Neurology, 26, 19–28.CrossRefGoogle ScholarPubMed
Nasreddine, Z. S. et al. (2005). The Montreal cognitive assessment: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695–699.CrossRefGoogle ScholarPubMed
Petersen, R. C. (2011). Mild cognitive impairment. New England Journal of Medicine, 364, 2227–2234.CrossRefGoogle ScholarPubMed
Pfeffer, R. I., Kurosaki, T. T., Harrah, C. H. Jr., Chance, J. M. and Filos, S. (1982). Measurement of functional activities in older adults in the community. Journal of Gerontology, 37, 323–329.CrossRefGoogle ScholarPubMed
Rossetti, H. C., Lacritz, L. H., Cullum, C. M. and Weiner, M. F. (2011). Normative data for the Montreal cognitive assessment (MoCA) in a population-based sample. Neurology, 77, 1272–1275.CrossRefGoogle Scholar
Roth, M. et al. (1986). CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. The British Journal of Psychiatry, 149, 698–709.CrossRefGoogle Scholar
Smith, T., Gildeh, N. and Holmes, C. (2007). The Montreal cognitive assessment: validity and utility in a memory clinic setting. Canadian Journal of Psychiatry, 52, 329–332.CrossRefGoogle Scholar
Tsai, C. F., Lee, W. J., Wang, S. J., Shia, B. C., Nasreddine, Z. and Fuh, J. L. (2011). Psychometrics of the Montreal cognitive assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysis. International Psychogeriatrics, 12, 1–8.Google Scholar
Waldron-Perrine, B. and Axelrod, B. N. (2012). Determining an appropriate cutting score for indication of impairment on the Montreal cognitive assessment. International Journal of Geriatric Psychiatry, 27, 1189–1194.CrossRefGoogle ScholarPubMed
Yesavage, J. A. et al. (1983). Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research, 17, 37–49.CrossRefGoogle Scholar